EU-IN_VITRO_MEDICAL_DEVICE_REG-ART_5_2_ANX_1

In Vitro Diagnostic Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Art. 5(2) and Annex I of Regulation (EU) 2017/746 on In Vitro Diagnostic Medical Devices, 5 May 2017, as corrected 27 December 2019

This list contains a non-exhaustive inventory of hazardous substances for purposes of Regulation (EU) 2017/746, including Chap. 2 (Placing on the market and putting into service) and Annex I (General Safety and Performance Requirements). It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

Last updated 26 april 2024. Database contains 4917 unique substances/entries.

Filter the list

Viser 1.751 - 1.800 af 4.917 resultater.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU_BA Directive 2000/54/EC	EU REACH: List of SVHC
Cladophialophora bantiana	-	-		F Fungi		Details
Clarified oils (petroleum), catalytic cracked; Heavy Fuel oil [A complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350°C (662°F). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] A complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350°C (662°F). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.	265-064-6	64741-62-4	Carc. 1B			Details
Clarified oils (petroleum), hydrodesulfurized catalytic cracked; Heavy Fuel oil [A complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 °C (662 °F). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] A complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350°C (662°F). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.	269-782-0	68333-26-6	Carc. 1B			Details
clethodim (ISO); (5RS)-2-{(1EZ)-1-[(2E)-3-chloroallyloxyimino]propyl}-5-[(2RS)-2-(ethylthio)propyl]-3-hydroxycyclohex-2-en-1-one	619-396-7	99129-21-2	Acute Tox. 4; Skin Sens. 1			Details
clodinafop-propargyl (ISO)	600-662-6	105512-06-9	Acute Tox. 4; STOT RE 2; Skin Sens. 1			Details
clomazone (ISO); 2-(2-chlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one	617-258-0	81777-89-1	Acute Tox. 4			Details
Clonorchis sinensis	-	-		P Parasites		Details
Clonorchisviverrini	-	-		P Parasites		Details
clopyralid (ISO); 3,6-dichloropyridine-2-carboxylic acid	216-935-4	1702-17-6	Eye Dam. 1			Details
clorofene; chlorophene; 2-benzyl-4-chlorophenol	204-385-8	120-32-1	Carc. 2; Repr. 2; Acute Tox. 4; Skin Irrit. 2; Skin Sens. 1; Eye Dam. 1; STOT RE 2			Details
Clostridium botulinum	-	-		B Bacteria and similar species		Details
Clostridium perfringens	-	-		B Bacteria and similar species		Details
Clostridium spp.	-	-		B Bacteria and similar species		Details
Clostridium tetani	-	-		B Bacteria and similar species		Details
clothianidin (ISO); (E)-1-(2-chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine	433-460-1	210880-92-5	Repr. 2; Acute Tox. 4; STOT SE 1			Details
Coal liquids, liq. solvent extn. [The substantially solvent-free product obtained by the distillation of the solvent from filtered coal extract solution produced by digesting coal in a liquid solvent. A black semi-solid, composed primarily of a complex combination of condensed-ring aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic compounds and other aromatic oxygen compounds, and their alkyl derivatives.] The substantially solvent-free product obtained by the distillation of the solvent from filtered coal extract solution produced by digesting coal in a liquid solvent. A black semi-solid, composed primarily of a complex combination of condensed-ring aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic compounds and other aromatic oxygen compounds, and their alkyl derivatives.	302-683-3	94114-48-4	Carc. 1B			Details
Coal liquids, liq. solvent extn. soln. [The product obtained by filtration of coal mineral matter and undissolved coal from coal extract solution produced by digesting coal in a liquid solvent. A black, viscous, highly complex liquid combination composed primarily of aromatic and partly hydro-genated aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic and other aromatic oxygen compounds and their alkyl derivatives.] The product obtained by filtration of coal mineral matter and undissolved coal from coal extract solution produced by digesting coal in a liquid solvent. A black, viscous, highly complex liquid combination composed primarily of aromatic and partly hydrogenated aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic and other aromatic oxygen compounds and their alkyl derivatives.	302-682-8	94114-47-3	Carc. 1B			Details
cobalt	231-158-0	7440-48-4	Carc. 1B; Muta. 2; Repr. 1B; Resp. Sens. 1; Skin Sens. 1			Details
cobalt carbonate	208-169-4	513-79-1	Carc. 1B; Muta. 2; Repr. 1B; Resp. Sens. 1; Skin Sens. 1		C Carcinogenic (article 57a) R Toxic for reproduction (article 57c)	Details
cobalt di(acetate)	200-755-8	71-48-7	Carc. 1B; Muta. 2; Repr. 1B; Resp. Sens. 1; Skin Sens. 1		C Carcinogenic (article 57a) R Toxic for reproduction (article 57c)	Details
cobalt dichloride	231-589-4	7646-79-9	Carc. 1B; Muta. 2; Repr. 1B; Acute Tox. 4; Resp. Sens. 1; Skin Sens. 1		C Carcinogenic (article 57a) R Toxic for reproduction (article 57c)	Details
cobalt dimolybdenum nickel octaoxide	268-169-5	68016-03-5	Carc. 1A; STOT RE 1; Skin Sens. 1			Details
cobalt dinitrate	233-402-1	10141-05-6	Carc. 1B; Muta. 2; Repr. 1B; Resp. Sens. 1; Skin Sens. 1		C Carcinogenic (article 57a) R Toxic for reproduction (article 57c)	Details
cobalt lithium nickel oxide	442-750-5	113066-89-0	Carc. 1A; Acute Tox. 2; STOT RE 1; Skin Sens. 1			Details
cobalt nickel dioxide	261-346-8	58591-45-0	Carc. 1A; STOT RE 1; Skin Sens. 1			Details
cobalt nickel gray periclase; C.I. Pigment Black 25; C.I. 77332 This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77332.	269-051-6	68186-89-0	Carc. 1A; STOT RE 1; Skin Sens. 1			Details
cobalt nickel oxide	620-395-9	12737-30-3	Carc. 1A; STOT RE 1; Skin Sens. 1			Details
cobalt oxide	215-154-6	1307-96-6	Acute Tox. 4; Skin Sens. 1			Details
cobalt sulfate	233-334-2	10124-43-3	Carc. 1B; Muta. 2; Repr. 1B; Acute Tox. 4; Resp. Sens. 1; Skin Sens. 1		C Carcinogenic (article 57a) R Toxic for reproduction (article 57c)	Details
cobalt sulfide	215-273-3	1317-42-6	Skin Sens. 1			Details
Coccidioides inunitis	-	-		F Fungi		Details
colchicine	200-598-5	64-86-8	Muta. 1B; Acute Tox. 2			Details
colecalciferol; cholecalciferol; Vitamin D3	200-673-2	67-97-0	Acute Tox. 2; STOT RE 1			Details
Coltivirus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.		Details
complex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated(n H2O,2 SUBSTANCE S171393	427-390-9	-	Skin Sens. 1			Details
condensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily; amino-ethyl-piperazine and triethylenetetramine) INDULIN MQK-1M	413-770-1	-	Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1			Details
constitutional isomers of penta-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside; constitutional isomers of hexa-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside; constitutional isomers of hepta-O-allyl-β-D-fructofuransoyl-α-D-glucopyranoside ALLYL SUCROSE	419-640-0	68784-14-5	Acute Tox. 4			Details
copper chloride; copper (I) chloride; cuprous chloride	231-842-9	7758-89-6	Acute Tox. 4			Details
copper dihydroxide; copper(II) hydroxide	243-815-9	20427-59-2	Acute Tox. 2; Acute Tox. 4; Eye Dam. 1			Details
copper flakes (coated with aliphatic acid)	-	-	Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2			Details
copper sulphate	231-847-6	7758-98-7	Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2			Details
copper sulphate pentahydrate	616-477-9	7758-99-8	Acute Tox. 4; Eye Dam. 1			Details
copper(II) carbonate-copper(II) hydroxide (1:1)	235-113-6	12069-69-1	Acute Tox. 4; Eye Irrit. 2			Details
copper(II) methanesulfonate KUPFER-II-METHANSULFONAT; KUPFERMETHANSULFONAT	405-400-2	54253-62-2	Acute Tox. 4; Eye Dam. 1			Details
coriandrol; (S)-3,7-dimethyl-1,6-octadien-3-ol; d-linalool	204-810-7	126-90-9	Skin Sens. 1B			Details
Coronaviridae	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.		Details
Corynebacterium diphtheriae	-	-		B Bacteria and similar species		Details
Corynebacterium minutissimum	-	-		B Bacteria and similar species		Details
Corynebacterium pseudotuberculosis	-	68583-16-4		B Bacteria and similar species		Details
Corynebacterium spp.	-	-		B Bacteria and similar species		Details

Viser 1.751 - 1.800 af 4.917 resultater.

Export search results to:

EU-IN_VITRO_MEDICAL_DEVICE_REG-ART_5_2_ANX_1

EU-IN_VITRO_MEDICAL_DEVICE_REG-ART_5_2_ANX_1

In Vitro Diagnostic Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Art. 5(2) and Annex I of Regulation (EU) 2017/746 on In Vitro Diagnostic Medical Devices, 5 May 2017, as corrected 27 December 2019

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 26 april 2024. Database contains 4917 unique substances/entries.

Footer Nav Items